Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- PMID: 30653247
- PMCID: PMC6916382
- DOI: 10.1002/mds.27602
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Erratum in
-
Erratum.Mov Disord. 2019 May;34(5):765. doi: 10.1002/mds.27684. Epub 2019 Mar 22. Mov Disord. 2019. PMID: 31091362 Free PMC article. No abstract available.
Abstract
Objective: To update evidence-based medicine recommendations for treating nonmotor symptoms in Parkinson's disease (PD).
Background: The International Parkinson and Movement Disorder Society Evidence-Based Medicine Committee's recommendations for treatments of PD were first published in 2002, updated in 2011, and now updated again through December 31, 2016.
Methods: Level I studies testing pharmacological, surgical, or nonpharmacological interventions for the treatment of nonmotor symptoms in PD were reviewed. Criteria for inclusion and quality scoring were as previously reported. The disorders covered were a range of neuropsychiatric symptoms, autonomic dysfunction, disorders of sleep and wakefulness, pain, fatigue, impaired olfaction, and ophthalmologic dysfunction. Clinical efficacy, implications for clinical practice, and safety conclusions are reported.
Results: A total of 37 new studies qualified for review. There were no randomized controlled trials that met inclusion criteria for the treatment of anxiety disorders, rapid eye movement sleep behavior disorder, excessive sweating, impaired olfaction, or ophthalmologic dysfunction. We identified clinically useful or possibly useful interventions for the treatment of depression, apathy, impulse control and related disorders, dementia, psychosis, insomnia, daytime sleepiness, drooling, orthostatic hypotension, gastrointestinal dysfunction, urinary dysfunction, erectile dysfunction, fatigue, and pain. There were no clinically useful interventions identified to treat non-dementia-level cognitive impairment.
Conclusions: The evidence base for treating a range of nonmotor symptoms in PD has grown substantially in recent years. However, treatment options overall remain limited given the high prevalence and adverse impact of these disorders, so the development and testing of new treatments for nonmotor symptoms in PD remains a top priority. © 2019 International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; evidence-based medicine; non-motor symptoms; randomized controlled trial.
© 2019 International Parkinson and Movement Disorder Society.
Similar articles
-
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.Mov Disord. 2011 Oct;26 Suppl 3(0 3):S42-80. doi: 10.1002/mds.23884. Mov Disord. 2011. PMID: 22021174 Free PMC article. Review.
-
International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.Mov Disord. 2018 Aug;33(8):1248-1266. doi: 10.1002/mds.27372. Epub 2018 Mar 23. Mov Disord. 2018. PMID: 29570866 Review.
-
The impact and management of nonmotor symptoms of Parkinson's disease.Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14. Am J Manag Care. 2011. PMID: 22087551 Review.
-
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472. JAMA Neurol. 2015. PMID: 25420207 Clinical Trial.
-
Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.Mov Disord. 2021 Dec;36(12):2821-2832. doi: 10.1002/mds.28763. Epub 2021 Aug 26. Mov Disord. 2021. PMID: 34448251
Cited by
-
Effect of acupuncture for non-motor symptoms in patients with Parkinson's disease: A systematic review and meta-analysis.Front Aging Neurosci. 2022 Oct 6;14:995850. doi: 10.3389/fnagi.2022.995850. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36275001 Free PMC article.
-
Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions.Behav Sci (Basel). 2021 Apr 17;11(4):54. doi: 10.3390/bs11040054. Behav Sci (Basel). 2021. PMID: 33920698 Free PMC article. Review.
-
Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review.Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588. Brain Sci. 2020. PMID: 32854426 Free PMC article. Review.
-
Clinical Features and Correlates of Poor Nighttime Sleepiness in Patients with Parkinson's Disease.Parkinsons Dis. 2020 Sep 14;2020:6378673. doi: 10.1155/2020/6378673. eCollection 2020. Parkinsons Dis. 2020. PMID: 33005317 Free PMC article.
-
Young Onset Parkinson's Disease: A Modern and Tailored Approach.J Parkinsons Dis. 2020;10(s1):S29-S36. doi: 10.3233/JPD-202135. J Parkinsons Dis. 2020. PMID: 32651336 Free PMC article. Review.
References
-
- Goetz C, Koller W, Poewe W. Management of Parkinson's disease: an evidence‐based review. Mov Disord 2002;17(suppl 4):S1‐S166. - PubMed
-
- Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society evidence‐based medicine review update: treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011;26(suppl 3):S2‐S41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous